Our study demonstrates that BET inhibition induces thrombocytopenia in vivo by altering GATA1 gene expression and its downstream genes, NFE2 and PF4, which regulate megakaryopoiesis and thrombopoiesis. This evidence concerns the gene DNER and Thrombocytopenia.